The Enterprise Value as of December 2025 (TTM) for Climb Bio, Inc. (CLYM) is 95.92M

According to Climb Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 95.92M. This represents a change of 12.73% compared to the average of 85.08M of the last 4 quarters.

Climb Bio, Inc. (CLYM) Historical Enterprise Value (quarterly & annually)

How has CLYM Enterprise Value performed in the past?

The mean historical Enterprise Value of Climb Bio, Inc. over the last ten years is 78.57M. The current 95.92M Enterprise Value has changed 12.11% with respect to the historical average. Over the past ten years (40 quarters), CLYM's Enterprise Value was at its highest in in the September 2024 quarter at 194.99M. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.

Climb Bio, Inc. (CLYM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Climb Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Climb Bio, Inc. (CLYM) Average Enterprise Value

How has CLYM Enterprise Value performed in the past?

The current Enterprise Value of Climb Bio, Inc. (CLYM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Climb Bio, Inc. (CLYM) Enterprise Value vs. Peers

How is CLYM’s Enterprise Value compared to its peers?

Climb Bio, Inc.’s Enterprise Value is greater than Entera Bio Ltd. (88.38M), greater than Spero Therapeutics, Inc. (83.18M), less than Seres Therapeutics, Inc. (194.69M), less than Anixa Biosciences, Inc. (154.73M), greater than Acumen Pharmaceuticals, Inc. (76.70M), greater than Inovio Pharmaceuticals, Inc. (94.56M), less than Actuate Therapeutics Inc (153.91M), less than Turn Therapeutics Inc. (122.05M), greater than VistaGen Therapeutics, Inc. (78.69M), less than Agenus Inc. (181.50M),

Build a custom stock screener for Climb Bio, Inc. (CLYM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Climb Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Climb Bio, Inc. (CLYM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Climb Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.